Board Co Advisory serves as Executive at Evolent Health, Inc., where they oversee executive responsibilities. Since joining the company, Board Co Advisory has executed 8 insider transactions totaling $122.6M, demonstrating a bearish approach to their equity position. Their most recent transaction on May 19, 2017 involved selling 1,000,000 shares valued at $24.3M.
Board Co Advisory currently holds 4,128,167 shares of Evolent Health, Inc. (EVH), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Board Co Advisory has been a net seller of EVH stock. They have purchased $0 and sold $122.6M worth of shares.
Board Co Advisory's most recent insider trade was on May 19, 2017, when they sold 1,000,000 shares at $24.30 per share.
Get notified when new Form 4 filings are submitted
| $N/A |
| Discretionary |
| May 1, 2017 | EVH | $6.2M | Sale | 317,712 | $19.53 | Discretionary |
| May 1, 2017 | EVH | $0 | Conversion | 317,712 | $N/A | Discretionary |
| Mar 28, 2017 | EVH | $41.4M | Sale | 2,118,078 | $19.53 | Discretionary |
| Mar 28, 2017 | EVH | $0 | Conversion | 2,118,078 | $N/A | Discretionary |
| Sep 22, 2016 | EVH | $7.1M | Sale | 317,712 | $22.50 | Discretionary |
| Sep 14, 2016 | EVH | $43.6M | Sale | 1,936,529 | $22.50 | Discretionary |